Fej-nyaki daganatok: vizsgálatok itt: Tajvan

In Tajvan 43 Also abroad 942

43 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

1/2. fázisTaking people
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Where
Changhua, Kaohsiung City, Tainan, Taipei
Életkor
18 év and over
People
340 worldwide
Run by
Inhibrx Biosciences, Inc
See details and how to joinNCT04198766
3. fázisTaking people
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Where
Bei Qu, Changhua, Keelung, Taichung, Taipei
Életkor
60 év and over
People
500 worldwide
Run by
Johnson & Johnson Enterprise Innovation Inc.
See details and how to joinNCT04892173 · EU 2024-520386-31-00
1/2. fázisTaking people
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Where
Changhua, Kaohsiung City, Taipei, Taoyuan
Életkor
18 év and over
People
287 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06385080 · EU 2023-508418-40-00
3. fázisTaking people
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Where
Changhua, Kaohsiung City, Taichung, Tainan, Taipei
Életkor
18 év and over
People
600 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07276399 · EU 2025-521917-24-00
2/3. fázisTaking people
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Where
Changhua, Kaohsiung City, Taichung, Taipei
Életkor
18 év and over
People
650 worldwide
Run by
Bicara Therapeutics
See details and how to joinNCT06788990 · EU 2024-519654-37-00
2. fázisTaking people
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Where
Taipei
Életkor
18 év and over
People
750 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00
2/3. fázisTaking people
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Where
Changhua, Kaohsiung City, Taichung, Tainan, Taipei, Taipei City
Életkor
18 év and over
People
450 worldwide
Run by
Inhibrx Biosciences, Inc
See details and how to joinNCT06295731
1/2. fázisTaking people
A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
Where
Changhua, Taipei
Életkor
18 év and over
People
235 worldwide
Run by
Alentis Therapeutics AG
See details and how to joinNCT06747585 · EU 2024-515459-39-00
No phaseTaking people
Effectiveness of Hydrogen Water Intervention on Acute Oral Inflammation, Oral Microbiota, and Pain Following Free Flap Reconstruction in Patients With Oral Cancer
Where
Kaohsiung City
Életkor
18 év and over
People
36
Run by
Kaohsiung Medical University Chung-Ho Memorial Hospital
See details and how to joinNCT07306546
2. fázisTaking people
A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Where
Taichung, Taipei
Életkor
18 év and over
People
150 worldwide
Run by
AbbVie
See details and how to joinNCT07744126 · EU 2025-524179-22-00
2. fázisTaking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
Életkor
18 év and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
1/2. fázisTaking people
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Where
Taichung, Tainan, Taipei
Életkor
18 év and over
People
680 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00
No phaseTaking people
Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer
Where
Taipei
Életkor
20 év to 100 év
People
800
Run by
Chang Gung Memorial Hospital
See details and how to joinNCT06111430
1/2. fázisTaking people
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Where
Kaohsiung City, New Taipei City, Taipei, Taoyuan
Életkor
18 év and over
People
862 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT05914116
1. fázisTaking people
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Where
Kaohsiung City, Taichung, Taipei, Taoyuan City
Életkor
18 év and over
People
325 worldwide
Run by
AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00
1. fázisTaking people
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Where
Kaohsiung City
Életkor
18 év and over
People
110 worldwide
Run by
EpiBiologics
See details and how to joinNCT07462377
3. fázisTaking people
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Where
Kaohsiung City, Taichung, Tainan, Taipei
Életkor
18 év and over
People
260 worldwide
Run by
Corbus Pharmaceuticals Inc.
See details and how to joinNCT07768189 · EU 2026-527123-94-00
3. fázisTaking people
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Where
Changhua, Kaohsiung City, Taichung, Taipei, Taoyuan
Életkor
18 év to 130 év
People
1145 worldwide
Run by
AstraZeneca
See details and how to joinNCT06129864
No phaseTaking people
Can Exercise Ameliorate Immunosenescence and Thereby Reduce Relapse in Head and Neck Cancer Patients
Where
New Taipei City
Életkor
20 év to 80 év
People
290
Run by
Chang Gung Memorial Hospital
See details and how to joinNCT06851988
No phaseTaking people
Skeletal Muscle Mass Changes on Images for Prediction of Prognosis After Exercise Training in HNSCC Patients
Where
New Taipei City
Életkor
20 év to 80 év
People
280
Run by
Chang Gung Memorial Hospital
See details and how to joinNCT06666881
2. fázisTaking people
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Where
Kaohsiung City, Taichung, Taipei
Életkor
18 év to 64 év
People
257 worldwide
Run by
AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00
2. fázisTaking people
Boron Neutron Capture Therapy With B10 L-BPA for Unresectable Recurrent Head and Neck Cancers
Where
Chiayi City, Taichung, Taipei
Életkor
18 év to 80 év
People
24
Run by
China Medical University Hospital
See details and how to joinNCT06952868
No phaseTaking people
Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT
Where
Hualien City
Életkor
30 év to 75 év
People
180
Run by
Tzu Chi University
See details and how to joinNCT07711626
No phaseTaking people
Effects of Far Infrared Rays and Transcutaneous Electrical Nerve Stimulation on Short Term Prognosis of Head and Neck Cancer Patients Receiving Curative Treatment
Where
Hualien City
Életkor
30 év to 85 év
People
102
Run by
Buddhist Tzu Chi General Hospital
See details and how to joinNCT07689019
1. fázisTaking people
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Where
Kaohsiung City, Taipei
Életkor
18 év and over
People
1006 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00